Infertility and Teratogenicity After Paternal Exposure to Systemic Dermatologic Medications: A Systematic Review
October 2018
in “
Journal of The American Academy of Dermatology
”
Studysummary This review indicates that many former FDA category D and X systemic dermatologic medications may negatively impact male fertility, with further research needed to assess potential teratogenic effects.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on jaad.org →